Abstract
The aim of the current study was to use a mouse model of allergic asthma to investigate whether cordycepin has antiasthmatic effects, and if so, to determine the mechanism of these effects. A total of 50 mice were randomly assigned to five experimental groups: control, model, dexamethasone (Dex, 2 mg/kg), and cordycepin (20–40 mg/kg). Histological studies were evaluated by the hematoxylin and eosin staining, OVA-specific serum and BALF IgE levels and Treg/Th17 cytokines were evaluated by enzyme-linked immunosorbent assay, and RORγt and Foxp3 were evaluated by western blot. Our study demonstrated that cordycepin inhibited OVA-induced increases in eosinophil count; IL-17A levels were recovered and increased IL-10 levels in bronchoalveolar lavage fluid. Histological studies demonstrated that cordycepin substantially inhibited OVA-induced eosinophilia in lung tissue. Western blot study demonstrated that cordycepin increased Foxp3 and inhibited RORγt. These findings suggest that cordycepin may effectively ameliorate the progression of asthma and could be used as a therapy for patients with allergic asthma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schuijs, M.J., M.A. Willart, H. Hammad, and B.N. Lambrecht. 2013. Cytokine targets in airway inflammation. Current Opinion in Pharmacology 13: 351–361.
Greenfeder, S., S.P. Umland, F.M. Cuss, R.W. Chapman, and R.W. Egan. 2001. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respiratory Research 2: 71–79.
Romagnani, S. 2000. The role of lymphocytes in allergic disease. The Journal of Allergy and Clinical Immunology 105: 399–408.
Mosmann, T.R., and K.W. Moore. 1991. The role of IL-10 in cross regulation of TH1 and TH2 responses. Immunology Today 12: A49–A53.
Brewer, J.M., M. Conacher, and C.A. Hunter. 1999. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4-or IL-13-mediated signaling. Journal of Immunology 163: 6448–6454.
Weaver, C.T., and R.D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages:a (co-)evolutionary perspective. Nature Reviews Immunology 12: 883–889.
Sakaguchi, S., M. Ono, and R. Setoguchi. 2006. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunological Reviews 212: 8–27.
Yoo, H.S., J.W. Shin, J.H. Cho, C.G. Son, Y.W. Lee, S.Y. Park, and C.K. Cho. 2004. Effect of cordyceps militarisextract on angiogenesis and tumor growth. Acta Pharmacologica Sinica 25: 657–665.
Yun, Y.H., S.H. Han, S.J. Lee, S.K. Ko, C.K. Lee, N.J. Ha, and K.J. Kim. 2003. Anti-diabetic effects of CCCA, cmESS, and cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Natural Product Sciences 9: 291–298.
Cho, M.A., D.S. Lee, M.J. Kim, J.M. Sung, and S.S. Ham. 2003. Antimutagenicity and cytotoxicity of cordycepin isolated from Cordyceps militaris. Food Science and Biotechnology 12: 472–475.
Choi, S.B., C.H. Park, M.K. Choi, D.W. Jun, and S.M. Park. 2004. Improvement of insulin resistance and insulin secretion by water extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipesin 90% pancreatectomized rats. Bioscience, Biotechnology, and Biochemistry 68: 2257–2264.
Sugar, A.M., and R.P. McCaffrey. 1998. Antifungal activity of 3′-deoxyadenosine (cordycepin). Antimicrobial Agents and Chemotherapy 42: 1424–1427.
De Julian-Ortiz, J.V., J. Galvez, C. Munoz-Collado, R. Garcia-Domenech, and C. Gimeno-Cardona. 1999. Virtual combinatorial syntheses and computational screening of new potential anti-herpes compounds. Journal of Medicinal Chemistry 42: 3308–3314.
Zhou, X., C.U. Meyer, P. Schmidtke, and F. Zepp. 2002. Effect of cordycepin on interleukin-10 production of human peripheral blood mononuclear cells. European Journal of Pharmacology 453(2–3): 309–317.
Oh, S.R., M.Y. Lee, K. Ahn, B.Y. Park, O.K. Kwon, H. Joung, J. Lee, D.Y. Kim, S. Lee, J.H. Kim, and H.K. Lee. 2006. Suppressive effect of verproside isolated from Pseudolysimachion longifolium on airway inflammation in a mouse model of allergic asthma. International Immunopharmacology 6: 978–986.
Djukanovic, R., W.R. Roche, J.W. Wilson, et al. 1990. Mucosal inflammation in asthma. American Review of Respiratory Disease 142: 434–457.
Duan, W., J.H. Chan, C.H. Wong CH, et al. 2004. Anti inflammatory effects of mitogen-activated protein kinase inhibitor U0126 in an asthma mouse model. Journal of Immunology 172: 7053–7059.
Jain, V.V., K. Kitagaki, T. Businga, et al. 2002. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. Journal of Allergy and Clinical Immunology 110(6): 867–872.
Elsner, J., and A. Kapp. 1999. Regulation and modulation of eosinophil effector functions. Allergy 54: 15–26.
Doganci, A., T. Eigenbrod, and N. Krug. 2005. The IL-6R alpha chain controls lung CD4+CD25+Treg development and function during allergic airway inflammation in vivo. Journal of Clinical Investigation 115: 313–325.
Acknowledgments
This work was supported by a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tianzhu, Z., Shihai, Y. & Juan, D. The Effects of Cordycepin on Ovalbumin-Induced Allergic Inflammation by Strengthening Treg Response and Suppressing Th17 Responses in Ovalbumin-Sensitized Mice. Inflammation 38, 1036–1043 (2015). https://doi.org/10.1007/s10753-014-0068-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-014-0068-y